Rates of adverse events in patients with ulcerative colitis undergoing colectomy during treatment with tofacitinib vs biologics: a multicenter observational study.
Gabriele DragoniTommaso InnocentiAurélien AmiotFabiana CastiglioneLaura MelottiStefano FestaEdoardo Vincenzo SavarinoMarie TruyensKonstantinos ArgyriouDaniele NovielloTamás MolnárVincent BouillonCristina BezzioPiotr EderSamuel Raimundo FernandesAnna KagramanovaAlessandro ArmuzziRaquel OliveiraAnna ViolaDavide Giuseppe RibaldoneIoannis DrygiannakisChiara ViganòFrancesca CalellaAntonietta Gerarda GravinaDaniela PuglieseMaria ChaparroPierre EllulSophie VieujeanMonica MillaFlavio Andrea Capriolinull nullPublished in: The American journal of gastroenterology (2024)
Pre-operative tofacitinib treatment demonstrated a post-operative safety profile comparable to biologics in patients with UC undergoing colectomy.